ASPIRA IVD Trademark

Trademark Overview

On Monday, June 6, 2016, a trademark application was filed for ASPIRA IVD with the United States Patent and Trademark Office. The USPTO has given the ASPIRA IVD trademark a serial number of 87062150. The federal status of this trademark filing is REGISTERED as of Tuesday, February 20, 2018. This trademark is owned by Vermillion, Inc.. The ASPIRA IVD trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Diagnostic testing and clinical research services for clinical trials and research studies in the field of oncology, gynecology and women's health
aspira ivd

General Information

Serial Number87062150
Word MarkASPIRA IVD
Filing DateMonday, June 6, 2016
Status700 - REGISTERED
Status DateTuesday, February 20, 2018
Registration Number5408258
Registration DateTuesday, February 20, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 16, 2017

Trademark Statements

Goods and ServicesDiagnostic testing and clinical research services for clinical trials and research studies in the field of oncology, gynecology and women's health
Disclaimer with Predetermined Text"IVD"

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, June 14, 2016
Primary Code044
First Use Anywhere DateThursday, March 31, 2016
First Use In Commerce DateThursday, March 31, 2016

Trademark Owner History

Party NameASPIRA WOMEN'S HEALTH INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressAUSTIN, TX 78738
Party NameVermillion, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressAustin, TX 78738
Party NameVermillion, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAustin, TX 78738
Party NameVermillion, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAustin, TX 78738

Trademark Events

Event DateEvent Description
Monday, February 20, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, August 12, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, February 20, 2018REGISTERED-PRINCIPAL REGISTER
Wednesday, January 17, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, January 16, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, January 16, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, January 14, 2018STATEMENT OF USE PROCESSING COMPLETE
Tuesday, January 9, 2018USE AMENDMENT FILED
Sunday, January 14, 2018SOU EXTENSION 1 GRANTED
Tuesday, January 9, 2018SOU EXTENSION 1 FILED
Sunday, January 14, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 9, 2018TEAS EXTENSION RECEIVED
Tuesday, January 9, 2018TEAS STATEMENT OF USE RECEIVED
Tuesday, July 11, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 16, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 16, 2017PUBLISHED FOR OPPOSITION
Wednesday, April 26, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, April 3, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 17, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 16, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 16, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 6, 2016ASSIGNED TO EXAMINER
Monday, October 17, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 17, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 20, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 20, 2016NON-FINAL ACTION E-MAILED
Tuesday, September 20, 2016NON-FINAL ACTION WRITTEN
Friday, September 16, 2016ASSIGNED TO EXAMINER
Tuesday, June 14, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 9, 2016NEW APPLICATION ENTERED

Related Keywords

aspira clinical research oncology gynecology women field health trials testing services